Shannon Kelley
Fortune : 6 M $ au 31/08/2026
Fortune : 6 M $ au 31/08/2026
Shannon Kelley currently works at Madrigal Pharmaceuticals, Inc., as Secretary, Chief Legal Counsel & Executive VP from 2024.
Ms. Kelley also formerly worked at Genzyme Corp., as Chief Compliance Officer-North America.
Ms. Kelley received her graduate degree from American University Washington College of Law and undergraduate degree from Edmund A. Walsh School of Foreign Service.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/08/2026 | 11 474 ( 0,05% ) | 6 M $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Conseiller Juridique Général | 05/08/2024 |
| Sociétés | Poste | Fin |
|---|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Compliance Officer | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Edmund A. Walsh School of Foreign Service
Edmund A. Walsh School of Foreign Service Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American University Washington College of Law
American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national